Abstract
Resources devoted to the development of burden-of-disease studies detract from much needed cost-effectiveness and cost-benefit studies. Practitioners need to help funders of burden-of-disease projects recognize the potential of all tools of decision analysis and economic evaluation in improving the efficiency and equity for the health care system.
Cite
CITATION STYLE
APA
Kymes, S. (2014, November 26). “Can We Declare Victory and Move On?” The Case Against Funding Burden-of-Disease Studies. PharmacoEconomics. Springer International Publishing. https://doi.org/10.1007/s40273-014-0200-8
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free